TRMED — Thor Medical ASA Share News
0.000.00%
- NOK1.49bn
- NOK1.48bn
- NOK0.44m
Brief: Thor Medical And Artbio Sign Strategic Long-Term Supply Agreement
Brief: Thor Medical Completes Herøya Pilot Facilities, Starts Commissioning
Brief: Thor Medical H1 EBITDA Turns To Loss Of NOK 12.7 Mln
Brief: Thor Medical Signs MoU With Steenkampskraal
Brief: Thor Medical Gets Grant Of NOK 6 Mln From Innovation Norway
Brief: Thor Medical Employs Brede Ellingsæter As CFO
Brief: Thor Medical H2 EBITDA Loss At NOK 6.8 Mln
Brief: Thor Medical Employs Jasper Kurth As New CEO
Brief: Thor Medical Signs LoI For Offtake With US, Scandinavian Based Clinical Trial Stage Cos
Brief: Thor Medical H1 Loss Before Tax At NOK 26.5 Mln
Brief: Nordic Nanovector ASA Says Acquisition Of Thor Medical AS Is Completed
Brief: Nordic Nanovector Appoints Alf Bjørseth As CEO
Brief: Nordic Nanovector Chairman Purchases 400.000 Shares In Co
Brief: Nordic Nanovector Announces Agreement To Acquire Thor Medical
Brief: Nordic Nanovector Publishes Data From Phase 2 Clinical Trials With Betalutin On European Clinical Trials Database
Brief: Nordic Nanovector Publishes Data From Phase 2 Clinical Trials With Betalutin
Brief: Nordic Nanovector H2 Comprehensive Loss Narrows To NOK 111 Mln
Brief: Nordic Nanovector ASA Announces Ludvik Sandnes Has Been Appointed Interim CEO And CFO
Brief: Nordic Nanovector Says Current Interim CEO And CFO Will Transition Out Of Co